biologit News

Biologit was featured in Silicon Republic in the article “Machine learning and AI to monitor medical literature”, where co-founders Nicole Baker and Bruno Ohana discuss how the company is meeting the challenges of automating medical literature monitoring for pharmacovigilance and safety surveillance of medical devices, cosmetics and nutraceuticals.

Biologit is proud to share that our CEO, Nicole Baker, is one of the four finalists in the "Woman AI Person of the Year" category for the 2023 annual AI Awards, sponsored by AI Ireland, taking place November, 21st in Dublin.

DIA Japan Annual Meeting 2023 is unique in presenting the entire healthcare value chain ranging from policy and regulations to R&D, marketing and access.

Held over three days under the theme of “Rebuilding Drug Development through Society 5.0", this edition of DIA represents a unique forum where every stakeholder is invited to discuss with their peers the future of drug development by combining the knowledge and skills of past, present, and future.

Connect with our team at the event 👇

Biologit CEO, Nicole Baker has been announced as a finalist for the Annual Technology Ireland 2023 in the category "Women in Tech Initiative of the Year." The winners will be revealed during the Technology Ireland Awards Ceremony on November 17 th in Dublin.

Biologit was shortlisted as one of only eight tech startups from Ireland in the KPMG Global Tech Innovator award. Co-founder Bruno Ohana discusses the vision and benefits of AI in pharmacovigilance at the KPMG global tech innovators event.

From the Sunday Business Post: Biologit, the AI-focused business which covers the pharma, medical devices, cosmetic and animal product sectors has recently completed a round of fundraising and is now focused on growth and development.